Barclays PLC Ptc Therapeutics, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Barclays PLC holds 167,012 shares of PTCT stock, worth $7.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

167,012

Previous 64,874 157.44%

Holding current value

$7.08 Million

Previous $1.98 Million 212.35%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$30.39 - $37.66 $3.1 Million - $3.85 Million	102,138 Added 157.44%	167,012 $6.2 Million
Q2 2024 Aug 14, 2024	SELL	$24.69 - $40.12 $691,912 - $1.12 Million	-28,024 Reduced 30.17%	64,874 $1.98 Million
Q1 2024 May 15, 2024	SELL	$24.15 - $31.95 $3.87 Million - $5.12 Million	-160,404 Reduced 63.33%	92,898 $2.7 Million
Q4 2023 Feb 15, 2024	BUY	$18.07 - $29.37 $2 Million - $3.25 Million	110,652 Added 77.57%	253,302 $6.98 Million
Q3 2023 Nov 07, 2023	BUY	$22.41 - $41.99 $682,048 - $1.28 Million	30,435 Added 27.12%	142,650 $3.2 Million
Q2 2023 Aug 03, 2023	BUY	$40.4 - $59.1 $1.1 Million - $1.6 Million	27,124 Added 31.88%	112,215 $4.56 Million
Q1 2023 May 04, 2023	SELL	$38.16 - $48.86 $1.79 Million - $2.29 Million	-46,855 Reduced 35.51%	85,091 $4.12 Million
Q4 2022 Feb 13, 2023	SELL	$33.53 - $54.79 $4,023 - $6,574	-120 Reduced 0.09%	131,946 $5.04 Million
Q3 2022 Nov 03, 2022	BUY	$41.85 - $53.85 $4.53 Million - $5.83 Million	108,178 Added 452.85%	132,066 $6.63 Million
Q2 2022 Aug 12, 2022	SELL	$25.6 - $45.23 $782,233 - $1.38 Million	-30,556 Reduced 56.12%	23,888 $957,000
Q1 2022 May 16, 2022	SELL	$33.33 - $44.6 $1.38 Million - $1.84 Million	-41,298 Reduced 43.13%	54,444 $2.03 Million
Q4 2021 Feb 14, 2022	BUY	$35.36 - $41.86 $1.28 Million - $1.52 Million	36,302 Added 61.07%	95,742 $3.81 Million
Q3 2021 Nov 09, 2021	BUY	$37.01 - $44.74 $1.62 Million - $1.96 Million	43,802 Added 280.1%	59,440 $2.21 Million
Q2 2021 Aug 13, 2021	SELL	$37.95 - $49.37 $2.69 Million - $3.5 Million	-70,943 Reduced 81.94%	15,638 $661,000
Q1 2021 May 13, 2021	SELL	$46.8 - $68.92 $1.1 Million - $1.62 Million	-23,497 Reduced 21.35%	86,581 $4.1 Million
Q4 2020 Feb 11, 2021	SELL	$47.96 - $67.64 $220,280 - $310,670	-4,593 Reduced 4.01%	110,078 $6.72 Million
Q3 2020 Nov 12, 2020	SELL	$45.41 - $57.07 $1.92 Million - $2.41 Million	-42,200 Reduced 26.9%	114,671 $5.36 Million
Q2 2020 Aug 12, 2020	SELL	$42.56 - $54.98 $777,826 - $1 Million	-18,276 Reduced 10.43%	156,871 $7.96 Million
Q1 2020 May 13, 2020	BUY	$32.37 - $59.36 $269,998 - $495,121	8,341 Added 5.0%	175,147 $7.81 Million
Q4 2019 Feb 10, 2020	SELL	$32.22 - $50.07 $3.91 Million - $6.08 Million	-121,499 Reduced 42.14%	166,806 $8.01 Million
Q3 2019 Nov 14, 2019	BUY	$33.82 - $48.17 $4.44 Million - $6.32 Million	131,140 Added 83.44%	288,305 $9.75 Million
Q2 2019 Aug 14, 2019	BUY	$35.42 - $45.0 $3.48 Million - $4.42 Million	98,301 Added 167.0%	157,165 $7.07 Million
Q1 2019 May 15, 2019	BUY	$28.09 - $39.49 $571,968 - $804,095	20,362 Added 52.89%	58,864 $2.22 Million
Q4 2018 Feb 14, 2019	SELL	$29.83 - $46.51 $355,871 - $554,864	-11,930 Reduced 23.66%	38,502 $1.32 Million
Q3 2018 Nov 14, 2018	BUY	$33.9 - $47.77 $222,723 - $313,848	6,570 Added 14.98%	50,432 $2.37 Million
Q2 2018 Aug 14, 2018	SELL	$25.7 - $47.88 $5.15 Million - $9.59 Million	-200,337 Reduced 82.04%	43,862 $1.48 Million
Q1 2018 May 15, 2018	BUY	$17.46 - $32.59 $3.72 Million - $6.95 Million	213,145 Added 686.37%	244,199 $6.61 Million
Q4 2017 Feb 14, 2018	SELL	$15.14 - $20.89 $393 - $543	-26 Reduced 0.08%	31,054 $518,000
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $522,454 - $671,638	31,080	31,080 $622,000

Others Institutions Holding PTCT

# of Institutions

219

Shares Held

78.2M

Call Options Held

111K

Put Options Held

30.6K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.03B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account